These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25143319)

  • 1. Prognosis of myocardial infarction with left ventricular dysfunction in the coronary revascularization era.Subanalysis of the Japanese Coronary Artery Disease (JCAD) Study.
    Kuga K; Yamasaki H; Hattori A; Xu DZ; Watanabe S; Arimoto T; Aonuma K; Kohro T; Yamazaki T; Nagai R
    Circ J; 2014; 78(10):2483-91. PubMed ID: 25143319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?].
    Lercher P; Rotman B; Scherr D; Kraxner W; Luha O; Klein W
    Wien Klin Wochenschr; 2003 Mar; 115(5-6):167-74. PubMed ID: 12741076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term outcome of surgical revascularization in patients with ischemic heart disease and left ventricular dysfunction].
    Wang R; Gao CQ; Xiao CS; Wu Y; Ren CL; Gong ZY; Wang Y; Liu GP; Wang MY
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1178-82. PubMed ID: 27117363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients?
    Tanno K; Miyoshi F; Watanabe N; Minoura Y; Kawamura M; Ryu S; Asano T; Kobayashi Y; Katagiri T;
    Circ J; 2005 Jan; 69(1):19-22. PubMed ID: 15635196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural History and Implantable Cardioverter-Defibrillator Implantation After Revascularization for Stable Coronary Artery Disease With Depressed Ejection Fraction.
    Lewis GF; Harless AC; Vazquez L; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Morin DP
    Clin Cardiol; 2015 Dec; 38(12):715-9. PubMed ID: 26442702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
    Siu CW; Pong V; Ho HH; Liu S; Lau CP; Li SW; Tse HF
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):231-5. PubMed ID: 19804551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery bypass grafting in patients with severe left ventricular dysfunction--early and mid-term outcomes.
    Shapira OM; Hunter CT; Anter E; Bao Y; DeAndrade K; Lazar HL; Shemin RJ
    J Card Surg; 2006; 21(3):225-32. PubMed ID: 16684046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the optimal left ventricular ejection fraction cut-off for risk stratification for primary prevention of sudden cardiac death early after myocardial infarction?
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Europace; 2014 Sep; 16(9):1315-21. PubMed ID: 24599939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of revascularization in patients with sustained ventricular arrhythmias, prior myocardial infarction, and preserved left ventricular ejection fraction.
    Mondésert B; Khairy P; Schram G; Shohoudi A; Talajic M; Andrade JG; Dubuc M; Guerra PG; Macle L; Roy D; Dyrda K; Thibault B; Barrero M; Diaz A; Kouz S; McNicoll S; Nowakowska D; Rivard L
    Heart Rhythm; 2016 Jun; 13(6):1221-7. PubMed ID: 26806581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial.
    Lopes RD; Alexander KP; Stevens SR; Reynolds HR; Stone GW; Piña IL; Rockhold FW; Elghamaz A; Lopez-Sendon JL; Farsky PS; Chernyavskiy AM; Diaz A; Phaneuf D; De Belder MA; Ma YT; Guzman LA; Khouri M; Sionis A; Hausenloy DJ; Doerr R; Selvanayagam JB; Maggioni AP; Hochman JS; Maron DJ
    Circulation; 2020 Nov; 142(18):1725-1735. PubMed ID: 32862662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.
    Mehra MR; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; O'Connor CM; Reynolds D; Walsh MN; Fonarow GC
    Heart Rhythm; 2009 Dec; 6(12):1727-34. PubMed ID: 19959119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function.
    Al-Dadah AS; Voeller RK; Rahgozar P; Lawton JS; Moon MR; Pasque MK; Damiano RJ; Moazami N
    J Cardiothorac Surg; 2007 Jan; 2():6. PubMed ID: 17222353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.